Literature DB >> 16848678

Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment.

David J Nutt1, David S Baldwin, Anita H Clayton, Rodney Elgie, Yves Lecrubier, Angel L Montejo, George I Papakostas, Daniel Souery, Madhukar H Trivedi, Andre Tylee.   

Abstract

During a special session, the faculty identified several specific areas related to the role of dopamine and norepinephrine in depression and antidepressant treatment that either warrant the clinician's attention or are in need of more research. Areas of interest include fatigue and lethargy in depression, treatment strategies for treatment-resistant depression, the somatic presentation of depression, neurobiology of fatigue and its role in determining treatment, symptom rating scales, and sexual side effects. In addition, the faculty discussed the importance of patient psychoeducation and self-management as well as the ways in which disease models of depression affect treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16848678

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

1.  A single neurotoxic dose of methamphetamine induces a long-lasting depressive-like behaviour in mice.

Authors:  Carlos D Silva; Ana F Neves; Ana I Dias; Hugo J Freitas; Sheena M Mendes; Inês Pita; Sofia D Viana; Paulo A de Oliveira; Rodrigo A Cunha; Carlos A Fontes Ribeiro; Rui D Prediger; Frederico C Pereira
Journal:  Neurotox Res       Date:  2013-09-26       Impact factor: 3.911

2.  Frontal Atrophy and Attention Deficits in Older Adults with a History of Elevated Depressive Symptoms.

Authors:  Vonetta M Dotson; Alan B Zonderman; Christos Davatzikos; Michael A Kraut; Susan M Resnick
Journal:  Brain Imaging Behav       Date:  2009-12-01       Impact factor: 3.978

3.  Attenuated dopamine signaling after aversive learning is restored by ketamine to rescue escape actions.

Authors:  Mingzheng Wu; Samuel Minkowicz; Vasin Dumrongprechachan; Pauline Hamilton; Lei Xiao; Yevgenia Kozorovitskiy
Journal:  Elife       Date:  2021-04-27       Impact factor: 8.140

4.  Effects of stimulation and blockade of d(2) receptor on depression-like behavior in ovariectomized female rats.

Authors:  Julia Fedotova
Journal:  ISRN Pharmacol       Date:  2012-03-01

5.  Early effects of duloxetine on emotion recognition in healthy volunteers.

Authors:  Susan Bamford; Ian Penton-Voak; Verity Pinkney; David S Baldwin; Marcus R Munafò; Matthew Garner
Journal:  J Psychopharmacol       Date:  2015-03-10       Impact factor: 4.153

6.  Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.

Authors:  Dara M Cannon; Jacqueline M Klaver; Summer A Peck; Denise Rallis-Voak; Kristine Erickson; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2008-10-22       Impact factor: 7.853

7.  Study protocol for a randomized controlled trial to explore the effects of personalized lifestyle advices and tandem skydives on pleasure in anhedonic young adults.

Authors:  Eeske van Roekel; Maurits Masselink; Charlotte Vrijen; Vera E Heininga; Tom Bak; Esther Nederhof; Albertine J Oldehinkel
Journal:  BMC Psychiatry       Date:  2016-06-04       Impact factor: 3.630

8.  Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.

Authors:  Jun-Xi Pan; Jin-Jun Xia; Feng-Li Deng; Wei-Wei Liang; Jing Wu; Bang-Min Yin; Mei-Xue Dong; Jian-Jun Chen; Fei Ye; Hai-Yang Wang; Peng Zheng; Peng Xie
Journal:  Transl Psychiatry       Date:  2018-07-10       Impact factor: 6.222

9.  The Response of Ventral Tegmental Area Dopaminergic Neurons to Bupropion: Excitation or Inhibition?

Authors:  Shirin Sadighparvar; Fereshteh Tale; Parviz Shahabi; Somayyeh Naderi; Firouz Ghaderi Pakdel
Journal:  Basic Clin Neurosci       Date:  2019-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.